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Background: Lactoperoxidase plays a key role in host defense by oxidizing thiocyanate to the bactericidal agent
hypothiocyanite.
Results: Urate is a good substrate for lactoperoxidase and competes with thiocyanate for oxidation in vitro.
Conclusion: Urate is a likely physiological substrate for lactoperoxidase.
Significance: Urate may influence the bactericidal activity of lactoperoxidase.
The physiological function of urate is poorly understood. It
may act as a danger signal, an antioxidant, or a substrate for
heme peroxidases. Whether it reacts sufficiently rapidly with
lactoperoxidase (LPO) to act as a physiological substrate re-
mains unknown. LPO is a mammalian peroxidase that plays a
key role in the innate immune defense by oxidizing thiocyanate
to the bactericidal and fungicidal agent hypothiocyanite. We
now demonstrate that urate is a good substrate for bovine LPO.
Urate was oxidized by LPO to produce the electrophilic inter-
mediates dehydrourate and 5-hydroxyisourate, which decayed
to allantoin. In the presence of superoxide, high yields of
hydroperoxides were formed by LPO and urate. Using stopped-
flow spectroscopy, we determined rate constants for the reac-
tion of urate with compound I (k1  1.1  107 M1 s1) and
compound II (k2 8.5 103 M1 s1). During urate oxidation,
LPO was diverted from its peroxidase cycle because hydrogen
peroxide reacted with compound II to give compound III. At
physiologically relevant concentrations, urate competed effec-
tively with thiocyanate, themain substrate of LPO for oxidation,
and inhibited production of hypothiocyanite. Similarly, hypothio-
cyanite-dependent killing of Pseudomonas aeruginosa was inhib-
itedbyurate.Allantoinwaspresent inhuman saliva andassociated
with the concentration of LPO. When hydrogen peroxide was
added to saliva, oxidationof uratewasdependent on its concentra-
tion andperoxidase activity.Our findings establishurate as a likely
physiological substrate forLPOthatwill influencehostdefenseand
give rise to reactive electrophilic metabolites.
Uric acid is an enigma in humanmetabolism. It accumulates
in its mono-anionic form urate to produce high concentrations
in cells and extracellular fluids such as lymphatic, interstitial,
synovial, cerebrospinal, and respiratory tract lining fluids (1),
but its precise physiological function remains unknown,
although it is suggested to be an antioxidant (2–5) and a danger
signal for inflammatory tissue damage (6). In contrast to other
mammals, in humans urate is considered the end product of
purine metabolism because the urate-catabolizing enzyme
uricase has been lost during primate evolution (7, 8). High con-
centrations of plasma uric acid are associated with adverse out-
comes in numerous inflammatory diseases (9–14), yet the
mechanisms linking it to a particular pathology for the most
part remain obscure. The major exception is activation of the
NLRP3 inflammasome by uric acid crystals in gout (15–17).
Typical urate concentrations in human serum range from 50
to 900 M (1). Concentrations of 200–300 M are considered
normal, whereas concentrations exceeding 420 M are
regarded hyperuricemic (18). Urate is also present in the airway
lining fluids at substantial concentrations (40–370 M) and is
considered to be an abundant small-molecule antioxidant in
the bronchoalveolar epithelial lining fluids (19). It can act as an
antioxidant because its one-electron reduction potential ((E°
(urate/urate) 0.56 V) is suitably poised for urate to intercept
damaging radicals but not propagate chain reactions (20). This
reduction potential alsomakes urate a likely substrate for heme
peroxidases. Indeed, it was shown early that mammalian per-
oxidases oxidize urate to allantoin (21, 22). Recently, kinetic
studies by us revealed urate to be a physiological substrate for
the neutrophil enzyme myeloperoxidase (MPO)3 (23). It has
also been suggested to be a substrate for the peroxidase cycle of
prostaglandin synthase (24). Whether urate is an important
physiological substrate for lactoperoxidase (LPO) is unknown.
LPO is a heme-containingmammalian enzyme found in exo-
crine secretion liquids, including saliva, tears, milk, and the lin-
ing fluids of the airway. Its main physiological function is the
oxidation of thiocyanate (SCN) to the bactericidal hypothio-
cyanite (OSCN), which makes LPO an important part of the
innate host defense (25–27). High concentrations of LPO are
present in human airway secretions, suggesting a function of
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LPO in the airway host defense against respiratory diseases
(28). Apart from its main substrate thiocyanate, LPO oxidizes a
variety of organic substrates, such as serotonin, tyrosine, tryp-
tophan, melatonin, tryptamine and N-acetyltryptamine (29),
thioanisole (30), the antibiotic benzylpenicillin (31), and adren-
aline (22). Given the promiscuity of LPO, we considered that it
may also readily oxidize urate.
In this study, we raised the question as to whether urate is a
likely physiological substrate for LPO and in what way this
might affect the efficiency of the bactericidal activity of the
enzyme. Our findings give new insights into human host
defense in extracellular fluids and how they may be influenced
by hyperuricemia.
EXPERIMENTAL PROCEDURES
Materials—Lactoperoxidase from bovine milk (purity index
A412/A280 0.88–0.95) was purchased from Sigma (L8257) as
lyophilized powder. Its concentration was determined using
412 112,000 M1 cm1 (32). Initial experiments with human
and bovine LPO showed near identical activity (33), and subse-
quent studies have used bovine LPO for kinetic studies.
Myeloperoxidase was obtained from Planta (Vienna, Austria)
and had a purity index of 0.82. Its concentration was deter-
mined using 430 89,000M1 cm1 (34). Catalase (C3155), cyto-
chrome c (C2506), 5,5-dithiobis-2-nitrobenzoic acid (DTNB,
D8130), superoxide dismutase (S7571), uric acid (U2625),
3,3,5,5-tetramethylbenzidine (TMB, 860336), and xanthine
oxidase (X1875) were also purchased from Sigma. To prevent
artifactual oxidation of the substrate, 10mMuratewas dissolved
in 40 mM sodium hydroxide containing 100 M diethylenetri-
aminepentaacetic acid and immediately diluted to the working
concentration in 50mM phosphate buffer, pH 7.4, or pH 7.0 for
the kinetic studies, and stored in the dark. The concentrations
of xanthine oxidase and cytochrome c were determined using
450 70,000M1 cm1 (35) and 410 106,100M1 cm1 (36),
respectively. Hydrogen peroxide (30%) was purchased from
BioLab, and the diluted solutions were prepared daily. The
hydrogen peroxide concentration was determined by using
240  43.6 M1 cm1 (37). Thio-2-nitrobenzoic acid (TNB)
was prepared from 5,5-dithiobis-2-nitrobenzoic acid (DTNB,
Ellman’s reagent) as described in Ref. 38.
Reaction of LPOwith Urate and Identification of the Reaction
Products by Mass Spectrometry—To identify the oxidation
products, urate (400 M) was oxidized by LPO (200 nM) and
hydrogen peroxide (100M) in 50mMphosphate buffer, pH7.4,
at 20–22 °C. Reactions were stopped after 10 min by the addi-
tion of 20 g/ml catalase. The samples were suspended in 20%
ammonium acetate buffer, pH 6.8, and 80% acetonitrile and
centrifuged for 1 min at 16,000 g. Urate, allantoin, and other
intermediates were detected by liquid chromatography with
mass spectrometry (LC/MS) as published previously (23). The
urate oxidation products were monitored as described before but
with the minor alteration of the chromatography by shortening
the re-equilibration to7minandchanging the source temperature
of themass spectrometer to 500 °C (23, 39). The [M-H] ions that
weremonitoredhadm/zvaluesof 167 (urate), 165 (dehydrourate),
183 (5-hydroxyisourate), and 157 (allantoin).
Urate Oxidation by LPO in the Presence of Superoxide—To
investigate the formation of urate hydroperoxides by xanthine
oxidase and LPO, organic hydroperoxides were detected using
a ferrous oxidation-xylenol orange (FOX) assay as described
previously (23, 37, 40–42). Reactions were started by adding
acetaldehyde (3 mM) to LPO (150 nM) and urate (200 M) in 50
mM phosphate buffer, pH 7.4.
Spectral Changes of LPO and Rate Constant for the Reaction
of Compound I and II with Urate—The kinetic experiments
were performed using equipment described previously (23) in
50 mM phosphate buffer, pH 7.0, at 25 °C. Urate photolysis (43)
was minimized by using a filter with a cut-off at 320 nm. It was
previously shown that equimolar concentrations of hydrogen
peroxide were required to form the maximum amount of LPO
compound I (29). This was confirmed by single mixing experi-
ments, and the maximum amount of compound I and a mini-
mal amount of compound II were present in the reaction mix-
ture after 100 ms (data not shown). Consequently, a delay time
of 100 ms was used for the double mixing experiments to study
the reaction of compound I with urate. For the reaction of com-
pound II with urate, either a delay time of 2 s was used so that
the reaction mixture contained the maximum amount of com-
pound II when the substrate was added, or compound II was
produced by reaction with urate as described above.
The rate constants of the reactions of LPOcompound I and II
with urate were determined as described previously for urate
oxidation bymyeloperoxidase (23). Final concentrationswere 1
M ferric LPO, 1 M hydrogen peroxide, and various concen-
trations of urate (0–25 M). To monitor the reaction of LPO
compound I with urate, spectral changes were followed
between 1ms and 1 s, and formation of compound II was mon-
itored at 432 nm. To establish the rate constant of the reaction
of LPO compound II with urate, spectral changes were moni-
tored between 1 ms and 200 s, and the decay of compound II
back to ferric LPO was observed at 432 nm. All data were fitted
by single exponential functions to determine the pseudo-first-
order rate constants kobs, carried out at least in duplicate for
each substrate concentration. Second-order rate constants
were calculated from the slope of the linear fit when the mean
values for kobs were plotted against substrate concentration.
Steady State Kinetics of the Reaction of LPO with Urate and
with Thiocyanate—The steady state kinetics of urate oxidation
by LPO were studied spectrophotometrically at room temper-
ature in 50mMphosphate buffer, pH 7.0. The reactionmixtures
contained 500 nM LPO and 30–400 M urate. Reactions were
initiated by the addition of 100 M hydrogen peroxide, and the
velocity of urate turnover was measured at 291 nm (291 
12,300 M1 cm1) using an Agilent 8453 diode array spectro-
photometer. Measurements were made every 20 s to avoid
urate photolysis. Additionally, the steady state kinetics of the
LPO/urate system were confirmed under the same reaction
conditions at 25 °C bymeasuring the consumption of hydrogen
peroxide using a hydrogen peroxide-sensitive electrode (ISO-
HPO-2 hydrogen peroxide sensor, World Precision Instru-
ments). To investigate whether LPO is inactivated by urate,
activity assays using TMB were performed as described previ-
ously (44) before and 20 min after incubation of LPO (500 nM)
with urate (100 M) and hydrogen peroxide (100 M).
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For comparisonwith urate turnover, the steady state kinetics
of thiocyanate oxidation by LPOwere studied bymeasuring the
consumption of hydrogen peroxide at 25 °C under the same
buffer and pH conditions. In addition, the amount of hypothio-
cyanite formedwasmeasured spectrophotometrically by assay-
ing the oxidation of TNB (412  14,100 M1 cm1) (38). The
reactionmixtures contained 50 nM LPO, 100M hydrogen per-
oxide, 20–1000M potassium thiocyanate, and 100MTNB in
50 mM phosphate buffer, pH 7.0.
Formation of Compound III during Steady State Oxidation of
Urate—To investigate the formation of LPOcompound III dur-
ing the steady state oxidation of urate, stopped-flow kinetic
studieswere performed in singlemixingmode at 25 °C in 50mM
phosphate buffer, pH 7.0. After preincubation of LPO (2 M
final concentration) with urate (200 M final concentration),
themixture was allowed to react with various concentrations of
hydrogenperoxide (200–800M), and formation of compound
III observed at 593 nm. The data were fitted with single expo-
nential functions to determine the pseudo-first-order rate con-
stant kobs, which was repeated in triplicate for each hydrogen
peroxide concentration. The slope of the mean values for kobs
versus substrate concentration yielded the second-order rate
constant for the reaction of compound II with hydrogen perox-
ide to form compound III.
Competition of Urate and Thiocyanate for LPO—To assess
the competition between urate and thiocyanate for oxidation
by LPO, the extent of urate oxidation was measured at a fixed
concentration of urate and variable concentrations of thiocya-
nate. Allantoin was measured as a stable product of urate oxi-
dation using liquid chromatography tandem mass spectrome-
try assay (LC/MS/MS) (39). Reactions were started by adding
hydrogen peroxide (20 M) to urate (400 M) and LPO (50 nM)
in 50 mM phosphate buffer, pH 7.4, in the presence of various
concentrations of thiocyanate (0–200 M) at 37 °C. After 30
min, reactions were stopped by the addition of 20 g/ml cata-
lase. The samples were suspended in 20% ammonium acetate
buffer, pH 6.8, and 80% acetonitrile and centrifuged for 1min at
16,000  g, and the accumulated allantoin was quantified by
LC/MS. The final concentrations of the product allantoin,
which depend upon the relative rates of the respective reac-
tions, were calculated for a range of thiocyanate concentra-
tions, and the IC50 was determined.
We also determined the competition betweenurate and thio-
cyanate by assessing the effect of urate on production of hypo-
thiocyanite, which was quantified bymeasuring the conversion
of GSH to GSSG. Reactions were started by adding 50 M
hydrogen peroxide to 200 M GSH, 10 nM LPO, 100 M thio-
cyanate, with or without the addition of 250 M urate in 10 mM
PBS (140mM sodium chloride), pH 6.8. Reactions were stopped
after 10 min by adding catalase (10 g/ml). Conversion of GSH
to GSSG was also measured after the addition of 2 g/ml glu-
cose oxidase to the above system to generate a continuous flux
of hydrogen peroxide. In this case, reactionmixtureswere incu-
bated for 1 h at 37 °C.N-Ethylmaleimide (4mM)was then added
to alkylate unreacted GSH, and samples were incubated for 30
min in the dark and then stored at20 °C until analyzed. Alky-
lated GSH and GSSG were analyzed by stable isotope dilution
LC/MS/MS as described previously (45). Mass spectrometry
analyses were performed using an Applied Biosystems 4000
QTRAP (Concord, Ontario, Canada) coupled to a Hypercarb
column (150  2.1 mm, 3 m, Thermo Scientific) operated at
60 °C.
Bacterial Killing Assay—We assessed the effect of urate on
the bactericidal activity of LPO by measuring the hypothiocya-
nite-dependent killing of a clinical isolate of Pseudomonas
aeruginosa. For viability assays, single colonies of P. aeruginosa
were cultured overnight in 3% tryptic soy broth (w/v; 37 °C; 200
rpm), harvested by centrifugation, washed, and suspended in
Hanks’ balanced salt solution (10 mM PBS, pH 7.4, containing
500MMgCl2, 1mMCaCl2, and 1mg/ml glucose). Bacterial cell
density was measured (A550), and cell number was calculated
from a standard curve based on colony counts. Hypothiocyan-
ite was generated by adding 50 M hydrogen peroxide to 10 nM
LPO, 100 M SCN, with or without 250 M urate in PBS at pH
6.8.After 10min at 20–22 °C, the remaining hydrogenperoxide
was removedby the addition of 10g/ml catalase.P. aeruginosa
were added to these solutions at a concentration of 1 105/ml
and incubated for 2 h with constant rotation (37 °C, 6 rpm).
Samples were then diluted in PBS, pH 6.8, and plated on blood
agar, and colonies were counted after overnight incubation at
37 °C. P. aeruginosa were also exposed to a continuous flux of
hypothiocyanite for 1 h with constant rotation (37 °C, 6 rpm)
using glucose oxidase (2 g/ml) and 10 nM LPO in the above
buffer. This system generated 1.5 M/min hydrogen peroxide.
After the addition of catalase (10 g/ml), samples were diluted
in PBS, pH 6.8, plated on blood agar, and counted after over-
night incubation at 37 °C.
Analysis of Peroxidases and Urate Oxidation in Human
Saliva—Ethical consent was obtained to collect saliva from
healthy subjects including an individual with MPO deficiency.
The content of MPO protein in isolated neutrophils from the
MPO-deficient individual was 3.5% of that from a healthy
donor as assessed by an MPO ELISA assay (46). This value is
similar to that previously reported for this individual (47).
Saliva was collected at least 2 h after donors had eaten and
immediately after they had rinsed theirmouths withwater. The
saliva was centrifuged for 25 min at 25,000 g, and the super-
natant was analyzed for its content of peroxidase activity, urate,
and allantoin. Peroxidase activity in saliva was measured by
monitoring the oxidation of TNB (412 14,100 M1 cm1) to
DTNB in a 96-well plate (Falcon 353072) and a microplate
spectrophotometer (SpectraMax 190, Molecular Devices) (38).
Saliva was diluted 10-fold into 50 mM phosphate buffer, pH
7.4, containing 100mM thiocyanate and 100MTNB, and reac-
tionswere started by adding 50Mhydrogen peroxide. The rate
of production of hypothiocyanite was compared with standard
curves obtained for bovine LPO and human MPO. Addition-
ally, MPO concentrations in the saliva samples were measured
using an activity ELISA as published previously (48). The con-
centration of LPO activity was then calculated by subtracting
MPO activity from total peroxidase activity and expressed as
bovine LPO equivalents. The concentrations of urate and allan-
toin in saliva supernatants were measured by mass spectrome-
try as described above. In a parallel experiment, hydrogen per-
oxide (50M)was added to the saliva samples and incubated for
30 min at 37 °C in the absence or presence of 1 mM sodium
Urate Oxidation by Lactoperoxidase
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azide. Reactions were stopped by the addition of 10 g/ml cat-
alase, and the changes in allantoin concentrations were mea-
sured using liquid chromatography with mass spectrometry.
Statistical Analysis—Differences between treatment groups
weredeterminedusingANOVAfollowedbyHolm-S˚ı´da´kposthoc
analysis. Differences from the control were considered significant
when p 0.05. Associationswere analyzed using Pearson’s corre-
lation coefficient and considered significant when p 0.05.
RESULTS
Reaction of LPOwith Urate and Identification of the Reaction
Products by Mass Spectrometry—Oxidation of urate by LPO
and hydrogen peroxide was demonstrated by showing a
decrease in absorbance at 290 nm and a corresponding increase
at 315 nm due to formation of products as reported previously
for MPO (23). Urate is known to readily photolyze (49), so pre-
cautions were made to minimize this by utilizing reduced light
intensity. Under these conditions, in the absence of either LPO
or hydrogen peroxide, no spectral changes were detected. The
maximum initial rate of oxidation of urate by LPO occurred
between pH 6 and 7, whereas an increase to pH 8 decreased the
rate of urate oxidation (data not shown). LC/MS analysis of the
reaction mixture revealed allantoin (m/z  157) as the major
stable reaction product, whereas dehydrourate (m/z 165) and
5-hydroxyisourate (m/z  183) were identified as reaction
intermediates (data not shown). In the absence of either hydro-
gen peroxide or LPO, only minor quantities of the reaction
products were detected, which correspond to a minimal
amount of substrate degradation by UV light as well as auto-
oxidation. These results confirm that urate is a substrate for
LPO and is oxidized to electrophilic species that break down to
allantoin (Fig. 1).
Urate Oxidation by LPO in the Presence of Superoxide—Pre-
viously, it was shown that when MPO oxidizes urate in the
presence of superoxide, a hydroperoxide is formed by the addi-
tion of superoxide to the urate radical (23). To determine how
effective LPO is at producing urate hydroperoxide, urate was
oxidized by LPO in the presence of hydrogen peroxide and
superoxide generated by xanthine oxidase and acetaldehyde.
Hydroperoxides were quantified using the FOX assay, which
is based on the oxidation of ferrous iron in the presence of
xylenol orange (42). Considerable concentrations of hydroper-
oxides were formed by this system (Fig. 2), substantially more
(3-fold) than previously observed with MPO under similar
conditions (23). When one of urate, LPO, xanthine oxidase, or
acetaldehyde was omitted, hydroperoxide formation was pre-
vented. The addition of catalase decreased hydroperoxide pro-
duction to almost control levels, indicating a requirement for
hydrogen peroxide. The addition of superoxide dismutase
decreased hydroperoxide production to control levels, demon-
strating that hydroperoxide formation was reliant on superox-
ide. Hence, LPO uses hydrogen peroxide and superoxide to
oxidize urate to a hydroperoxide.
Spectral Changes of LPO and Rate Constant for the Reaction
of Compound I and II with Urate—The rate constants for the
reactions of urate with compound I and II were determined by
stopped-flow kinetic studies. To determine the ideal delay
times for the sequential mixing experiments, a single mixing
experiment was performed where hydrogen peroxide was
added to ferric LPO.Upon the addition of hydrogen peroxide to
LPO, a decrease of absorbance was observed at 412 nm, which
corresponds to the formation of compound I. The maximum
concentration of compound I was found at 100 ms, which was
therefore used as the delay time. After 100 ms, an absorbance
shift from412 nm to 432 nmwasmonitored andwas completed
in 2 s. These spectral changes indicate the conversion of com-
pound I to II. In the absence of substrate, the absorbance of
FIGURE 1. Potential reaction pathways for urate radicals that are formed
whenurate isoxidizedbyLPO.Dehydrourate, 5-hydroxyisourate, andallan-
toin were detected directly by mass spectrometry. The structure of urate
hydroperoxide is a proposal only. Straight arrows represent direct reactions,
and dashed arrows represent breakdown pathways.
FIGURE2.Formationofhydroperoxidesduringoxidationof uratebyLPO
in thepresenceof superoxide. For the complete system, urate (200M)was
incubated with LPO (150 nM) and xanthine oxidase (XO, 200 nM) in 50 mM
phosphate buffer, pH 7.4. Reactions were started by the addition of acetalde-
hyde (Acet, 3mM) to produce a superoxide flux of 6M/min and stopped after
30 min by adding catalase (100 g/ml). Hydroperoxides were quantified by
the FOX assay and were expressed as hydrogen peroxide equivalents. When
added to the reaction system, catalase (Cat) and superoxide dismutase (SOD)
werepresent at 100 and20g/ml, respectively. Data aremeans and rangesof
at least duplicate experiments.
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compound II at 432 nm remained stable for 10 s and decayed
very slowly afterward.
To determine the rate constant of the reaction of compound
I with urate, ferric LPO was allowed to react with hydrogen
peroxide for 100 ms followed by the addition of urate (0–25
M) to reduce compound I. Spectral changes showed a rapid
conversion of compound I (max  412 nm) to compound II
(max 432 nm) over 50ms (Fig. 3A). Kinetic traces weremon-
itored at 432 nm to follow compound II formation for each
substrate concentration and fitted with single exponential
functions (Fig. 3B). The observed pseudo-first-order rate con-
stants kobs of compound II formation were linearly dependent
on substrate concentration (Fig. 3C). The line of best fit had a
slope of (1.1  0.1)  107 M1 s1, which corresponds to the
second-order rate constant of the reaction of LPO compound I
with urate.
Previously, it was suggested that compound I of LPO can
isomerize so that the porphyrin radical is transferred to an
amino acid residue and that this species is spectrally identical to
compound II (50). Therefore, a species with spectral character-
istics of compound II was formed either through decay of com-
pound I by increasing the delay time to 2 s or by reduction of
compound I by urate as described above. The former method
could give isomerized compound I or authentic compound II,
whereas the secondmethod would give authentic compound II
only. In both cases, upon the addition of urate (0–200 M) to
compound II, spectral changes revealed its conversion (max
432 nm) back to the ferric enzyme (max 412 nm) over 60 s, as
well as an isosbestic point at 423 nm (Fig. 4A). Kinetic traces
weremonitored at 432nm to follow the reduction of compound
II and were fitted with single exponential functions (Fig. 4B).
FIGURE3.Determinationof the rate constant for the reactionofLPOcom-
pound Iwithurate. LPO (1M)was premixedwith hydrogenperoxide (1M)
to form compound I at 25 °C in 50mM phosphate buffer, pH 7.0. After a delay
time of 100 ms, urate was added (0–25 M). All solutions were prepared
freshly and kept in the dark to avoid photolysis. A, spectral changes after the
addition of urate (2.5M) followedbetween 3ms (thick black line) and 200ms
(gray line); only representative spectra are shown. B, formation of compound
II in Awasmonitored at 432 nm (gray dots), and the data were fitted by single
exponential functions (black line). C, the averaged observed rate constants
kobs were plotted against the concentration of urate (black dots). Data are
means and standard deviations of at least triplicatemeasurements. The slope
of the linear fit corresponds to the second-order rate constant of the reaction
of LPO compound I with urate.
FIGURE4.Determinationof the rate constant for the reactionofLPOcom-
pound II with urate. LPO (1 M) was premixed with hydrogen peroxide (1
M) to form compound I at 25 °C in 50 mM phosphate buffer, pH 7.0. After a
delay time of 100 ms or 2 s, urate was added (0–200 M). A, spectral changes
after theadditionofurate (10M) followedbetween1ms (thick black line) and
80 s (gray line); only representative spectra are shown (2-s delay time). B,
reduction of compound II in Awas monitored at 432 nm (gray dots), and the
data were fitted to a single exponential function (black line). C, the averaged
observed rate constants kobs were plotted against the concentration of urate
(black dots). Data are means and ranges of at least duplicate measurements.
The slope of the linear fit corresponds to the second-order rate constant of
the reaction of LPO compound II with urate.D, the plot of averaged observed
rate constants versus urate concentration levels off at high urate concentra-
tion. Data are means and ranges of duplicate experiments (black dots) and
were fitted to a rectangular hyperbola (gray line) using Equation 1.
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The observed pseudo-first-order rate constants kobs were inde-
pendent of the method in which compound II was formed and
revealed a linear dependence on substrate concentration for up
to 30Murate (Fig. 4C). The line of best fit had a slope of (8.5
0.4)  103 M1 s1, which represents the second-order rate
constant of the reaction of LPO compound II with urate. The
intercept of the fitted line with the y axis was 0.015 0.006 s1
and corresponds to the spontaneous decay of compound II.
These results suggest that LPO has only one form of compound
II as previously argued (51). Upon increasing urate concentra-
tions to 200M, the plot of the observed pseudo-first-order rate
constants kobs versus urate concentration for the reaction of
compound II with urate plateaus (Fig. 4D), indicating a binding
interaction between compound II and urate, which can be
described as follows (52–54).
CmpdII UrateL|;
k
k
CmpdII:UrateO¡
krxn
Ferric Urate Radical
REACTION 1
As a result, kobs versus urate concentration can be fitted to a
rectangular hyperbola, according to the following equation.
kobs
krxn
Kapp
[Urate]
 1
(Eq. 1)
where
Kapp
k krxn
k	
(Eq. 2)
The value for the apparent dissociation constantKapp (200
30)Mwas directly derived from the nonlinear fit shown in Fig.
4D. We would expect a similar plot of kobs versus urate concen-
tration to level off at high urate concentrations for the reaction
of compound I with urate. Unfortunately, we were not able to
measure these rate constants because of the high reactivity of
compound I toward urate, leading to rates that are beyond the
detection limit of the instrument at high urate concentrations.
Steady State Kinetics of the Reaction of LPO with Urate and
with Thiocyanate—To understand how urate and thiocyanate
may compete as substrates for LPO, the steady state kinetics of
their oxidation by the enzyme were studied and compared.
Hydrogen peroxide consumption was measured for both sub-
strates using a hydrogen peroxide-sensitive electrode (Fig. 5A).
Additionally, urate oxidation was followed directly at 291 nm,
and the formation of hypothiocyanite was monitored by
recording its oxidation of TNB. The Michaelis-Menten curves
are shown in Fig. 5, B and C, and the kinetic parameters, which
were independent of the methods used to measure them, are
listed in Table 1. These parameters reveal that thiocyanate is
preferred to urate as a substrate for LPO but suggest that,
depending on relative concentrations, the two substrates
should compete for oxidation by the enzyme. The kinetic traces
of urate oxidation were characterized by an initial phase of fast
urate depletion followed by a slower second phase. To investi-
gate whether the slow phase was due to irreversible enzyme
FIGURE 5. Steady state oxidation of urate and thiocyanate by LPO. A, loss
of hydrogen peroxide during thiocyanate (dotted line) and urate (solid line)
oxidation by LPOmeasured continuously using a hydrogen peroxide specific
electrode. Reaction mixtures contained 100 M hydrogen peroxide, 50 nM
LPO, and 1 mM thiocyanate or 100 M hydrogen peroxide, 500 nM LPO, and
300M urate, respectively, in 50mM phosphate buffer, pH 7.0, at 25 °C. Arrow
indicates when LPO was added. B, initial phase of urate degradation was
monitored at 291 nmexcept at high urate concentrations (
200M), when it
was followed by recording hydrogen peroxide depletion. Inset shows data
obtained for the secondary phase. Reaction mixtures contained 500 nM
LPO, 100 M hydrogen peroxide, and 30–400 M urate. The velocities
were plotted against substrate concentration (black dots) and were fitted
to the Michaelis-Menten equation (gray lines). C, oxidation of thiocyanate
by LPO was monitored by measuring the loss of hydrogen peroxide. Reac-
tion mixtures contained 50 nM LPO, 100 M hydrogen peroxide, and
20–1000 M thiocyanate. The velocities were verified by following the
oxidation of TNB by hypothiocyanite at 412 nm. These experiments were
performed under the same reaction conditions with 100 M TNB added to
the reaction mixture. Data are means and standard deviations of at least
triplicate experiments.
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inhibition, activity assays using TMB were performed before
and after reaction of LPO with urate. No change in peroxidase
activity occurred after reaction with hydrogen peroxide and
urate (data not shown).
Formation of Compound III during Steady State Oxidation of
Urate—To understand why urate oxidation by LPO was char-
acterized by an initial fast phase, we monitored the enzyme
spectrally and observed that it was present as compound III
during the steady state of urate turnover by LPO (Fig. 6A).
When LPO and urate were allowed to react with various con-
centrations of hydrogen peroxide, spectral changes revealed a
conversion of compound II (Soret  432 nm,   542 nm,
	 574 nm) to compound III (Soret 428 nm,  555 nm,
	 593 nm) over 60 s, as well as an isosbestic point at 431 nm
(Fig. 6A). Kinetic traces were monitored at 593 nm and fitted
with single exponential functions for each hydrogen peroxide
concentration (Fig. 6B). The observed pseudo-first-order rate
constants kobs of compound III formation were linearly
dependent on the concentration of hydrogen peroxide (Fig.
6C), and the linear fit had a slope of (220  15) M1 s1. This
value corresponds to the second-order rate constant of the
reaction of LPO compound II with hydrogen peroxide to form
compound III (55). The intercept of the fitted line with the y
axis was0.007 0.008 s1. The fact that the fitted line inter-
cepts the origin strongly suggests that compound III is formed
only by the reaction of compound II with hydrogen peroxide.
Urate and Thiocyanate as Competing Substrates for LPO—
Next we investigated the direct competition between urate and
thiocyanate for oxidation by LPO. First, we determined the
effect of thiocyanate on urate oxidation bymeasuring its ability
to inhibit the accumulation of allantoin. Reactions were
allowed to proceed long enough so that all the hydrogen perox-
ide was used by LPO. In the absence of thiocyanate, about half
the hydrogen peroxide was accounted for by the accumulation
of allantoin. Thiocyanate inhibited the extent of allantoin for-
mation in a concentration-dependent manner. It inhibited by
50% at a concentration of 36 M (IC50) when 400 M urate and
20 M hydrogen peroxide were present in the reaction mixture
(Fig. 7). The obtained IC50 was confirmed assuming only direct
competition between thiocyanate and urate with compound I
and using the respective rate constants (kSCN 2.0 108 M1
s1; kurate 1.1 107 M1 s1). These values yield a calculated
IC50 of 24 M.
To confirm the influence of urate on the capability of LPO to
oxidize thiocyanate, the production of hypothiocyanite by LPO
wasmeasured by detecting the oxidation ofGSH toGSSG in the
absence and presence of urate. Reactionswere run for sufficient
time so that the LPO/thiocyanate system could just consume all
added hydrogen peroxide. In the absence of urate, LPO used
hydrogen peroxide and thiocyanate to produce super-stoichio-
metric concentrations of GSSG (Fig. 8A). This result is in
accord with the formation of a radical intermediate of thiocya-
TABLE 1
Steady state kinetic parameters for the oxidation of urate and thiocy-
anate by LPO
Km and Vmax were determined by fitting the kinetic data in Fig. 5 according to
Michaelis-Menten kinetics. The catalytic rate constant kcat was calculated by divid-
ing Vmax by the concentration of LPO heme. The specificity constant kx was cal-
culated by dividing kcat by Km.
LPO urate
(initial phase)
LPO urate
(secondary phase) LPO SCN
Km (M) 100 20 220 30 340 60
kcat (s1) 0.56 0.06 0.13 0.01 180 20
kx (M1 s1) 5.6 103 580 5.5 105
FIGURE6.Determinationof the rate constant for the reactionofLPOcom-
pound II with hydrogen peroxide to form compound III. LPO (2 M) was
preincubated with urate (400 M) and then allowed to react with various
concentrations of hydrogen peroxide (200–800 M) at 25 °C in 50 mM phos-
phate buffer, pH 7.0. A, representative spectral changes followed between 5
ms (thick black line) and 80 s (gray line) using 200 M H2O2. Inset shows the 	
andbands ingreater detail.B, the formationof compound IIIwasmonitored
at 593nm (graydots), and thedatawere fittedby single exponential functions
(black line); representative data were obtained using 200 M H2O2. C, the
averaged observed rate constants kobs were plotted against the concentra-
tion of hydrogen peroxide (black dots). Data are means and standard devia-
tions of triplicatemeasurements. The slopeof the linear fit corresponds to the
second-order rate constant of the reaction of LPO compound II with hydro-
gen peroxide to form compound III.
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nate by peroxidases under similar reaction conditions (56, 57).
In the presence of urate, hypothiocyanite production was sub-
stantially decreased when a bolus of hydrogen peroxide was
added (Fig. 8A), confirming that urate is capable of competing
with thiocyanate for oxidation.When glucose oxidase was used
to generate a flux of hydrogen peroxide and ensure a low steady
state concentration of this substrate, urate also inhibited the
production of hypothiocyanite (Fig. 8B). In both cases, urate
inhibited considerably more than the 10% that would be
expected if it was acting only by competingwith thiocyanate for
oxidation by compound I. Thus, urate inhibits production of
hypothiocyanite via a pathway in addition to its reaction with
compound I.
Inhibition of LPO-dependent Bacterial Killing by Urate—To
investigate whether urate affects the ability of LPO to kill path-
ogenic bacteria, we determined the extent towhich it prevented
killing of P. aeruginosa by LPO, thiocyanate, and hydrogen per-
oxide. Under the conditions of our assay, LPO promoted sub-
stantial killing of P. aeruginosa in the presence of thiocyanate
and hydrogen peroxide (Fig. 9A). A similar degree of killing was
observed when hydrogen peroxide was supplied slowly by glu-
cose oxidase (Fig. 9B). In both cases, killing was reliant on the
presence of LPO, thiocyanate, and hydrogen peroxide. Urate, at
normal physiological concentrations (1, 19), inhibited killing
either in the presence of a bolus of hydrogen peroxide or when
it was generated as a slow flux. These results suggest that at
physiologically likely concentrations of both urate and thiocy-
anate, urate will interfere with the hypothiocyanite-dependent
killing of bacteria by LPO.
Peroxidase Levels and Urate Oxidation in Human Saliva—
To establish the physiological importance of urate oxidation by
LPO, wemeasured urate oxidation in human saliva. Previously,
it was demonstrated that saliva supernatants contain predom-
inantly LPO with variable concentrations of MPO. No other
proteins with peroxidase activity were detected, including
eosinophil peroxidase (58). All our subjects had detectable con-
centrations of LPO activity in saliva supernatants in agreement
with previous studies (Fig. 10A) (58, 59). Four subjects, includ-
ing one with MPO deficiency, had very low levels of detectable
MPO activity. Allantoin was present in saliva supernatants and
was associated with the activity of LPO (r  0.77; p  0.001)
(Fig. 10B) but notMPO (not shown).When hydrogen peroxide
was added to saliva supernatants, there was a significant
increase in allantoin that did not occur in the presence of azide,
a peroxidase poison (Fig. 10C). The concentration of allantoin
increased in all samples, including those from individuals with
low MPO and that from a person with MPO deficiency. The
increase in allantoin concentration upon the addition of hydro-
gen peroxide to the saliva was dependent on its concentration
of urate (r 0.73; p 0.003) (Fig. 10D) but not the concentra-
tions of peroxidases (not shown). Collectively, these results sug-
gest that the LPO present in saliva promotes the oxidation of
urate.
DISCUSSION
In this investigation, we have shown that urate is an excellent
substrate for compound I of LPO as part of the classical perox-
FIGURE 7. Thiocyanate and urate compete as substrates for LPO. LPO (50
nM) was incubated with urate (400M) and various concentrations of thiocy-
anate (0–200 M) in 50 mM phosphate buffer, pH 7.4. Reactions were started
by the addition of hydrogen peroxide (20M) and stopped by the addition of
20g/ml catalase. Allantoin formationwasmeasured by LC/MS. The concen-
tration of thiocyanate, when allantoin formation is inhibited by 50% (IC50),
was determined by fitting the data as described under “Experimental Proce-
dures” (solid line). Data are means and ranges of duplicate experiments.
FIGURE 8. Effect of urate on LPO-mediated production of hypothiocyan-
ite. The formation of hypothiocyanite by LPO was measured as oxidation of
GSH to GSSG. A, hypothiocyanite was generated by the addition of 50 M
H2O2 to 10 nM LPO and 100M thiocyanate in the presence or absence of 250
M urate in 10 mM phosphate buffer, pH 6.8. After a 10-min incubation at
roomtemperature, 10g/ml catalasewas added followedbyN-ethylmaleim-
ide. Data aremeans and standarddeviations of five individual experiments. B,
hypothiocyanite was produced over 1 h at 37 °C by incubation of 2 g/ml
glucose oxidase (GO) with 10 nM LPO, 100M thiocyanate, and 200MGSH in
the presence or absence of 250 M urate in 10 mM phosphate buffer, pH 6.8.
Reactions were stopped by adding catalase (20 g/ml), and then unreacted
GSHwasalkylatedwith4mMN-ethylmaleimide.Data aremeansand standard
deviations for a representative experiment of 3–4 separate experiments.
Datawere analyzedbyANOVAusingHolm-S˚ı´da´k post hoc analysis. *,p0.05
for comparisons versus the complete reaction system.
Urate Oxidation by Lactoperoxidase
21944 JOURNAL OF BIOLOGICAL CHEMISTRY VOLUME 289•NUMBER 32•AUGUST 8, 2014
 by guest on Septem
ber 18, 2020
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
idase cycle and can therefore be expected to be a physiological
substrate for the enzyme. Urate also reacts well with compound
II, but this reaction is in competition with the conversion of
compound II to compound III by hydrogen peroxide (Fig. 11).
Based on our current findings and the demonstration that urate
is a substrate for MPO, urate should now be recognized as a
peroxidase substrate that will influence the activity of these
enzymes and give rise to potentially toxic electrophiles. Urate
should not be considered as simply the final inert product of
purine metabolism. The precise effect urate has on production
of hypothiocyanite and the bactericidal activity of LPO will
depend on the relative concentrations of urate and thiocyanate
as well as the local concentration of hydrogen peroxide.
As described previously for other peroxidases, the urate rad-
icals produced by LPO will give rise to dehydrourate, 5-hy-
droxyisourate, and allantoin as outlined in Fig. 1 (23, 60). Dehy-
drourate and 5-hydroxyisourate are electrophilic species that
are potentially toxic and are likely to affect host defense as well
as the inflammatory response to bacteria. The absence of 5-hy-
droxyisourate hydrolase in knock-out mice predisposes them
to liver cancer (61), which demonstrates that these electro-
philes are indeed toxic. In the presence of superoxide, we have
shown that LPO catalyzes the production of another electro-
phile, urate hydroperoxide. The suggested structure and forma-
tion of urate hydroperoxide via the addition of superoxide to
the urate radical are shown in Fig. 1. We would expect urate
hydroperoxides to make additional contributions to oxidative
stress and propagate the toxicity of superoxide (62). However,
in a physiological environment, antioxidants such as ascorbate
may interfere by reducing urate radicals and limiting the for-
mation of the electrophilic species of urate. The effects of ascor-
bate on the LPO/urate system will be the subject of future
studies.
Stopped-flowkinetics showed that the rate constant for urate
oxidation by compound I (1.1 107 M1 s1) is the largest for
any organic substrate of LPO studied to date (29). It is 5-fold
greater than that for serotonin (E° (serotonin/serotonin) 
0.65 V), the next best organic substrate, and similar to that for
nitrite (2  107 M1 s1) (63). The low reduction potential of
urate (E° (urate/urate) 0.56 V) (20) should facilitate its oxi-
dation by compound I. Additionally, its negative charge, like
FIGURE 9. Effect of urate on killing of P. aeruginosa by LPO. A, hypothio-
cyanite was generated by the addition of 50 M hydrogen peroxide to 10 nM
LPO and 100M thiocyanate in the presence or absence of 250Murate in 10
mMphosphatebuffer, pH6.8. After a 10-min incubation at roomtemperature,
catalase (10 g/ml) was added to remove residual hydrogen peroxide. Bac-
teria (1 105/ml) were then added and incubated for 2 h at 37 °Cwith gentle
rotation. B, P. aeruginosa were incubated for 1 h (37 °C, 6 rpm) with 2 g/ml
glucose oxidase, 10 nM LPO, and 100 M thiocyanate in the presence or
absence of 250 M urate in 10 mM phosphate buffer, pH 6.8, containing 1
mg/mlglucose. This systemgenerated1.5Mhydrogenperoxide/min. Cat-
alase (10g/ml) was added prior to dilution and plating. Data aremeans and
standard errors of 3–4 separate experiments. Data were analyzed by ANOVA
using Holm-S˚ı´da´k post hoc analysis. *, p  0.05 for comparisons versus the
complete reaction system.
FIGURE 10. Urate oxidation by peroxidases in human saliva. A, LPO and
MPO activities weremeasured in diluted saliva supernatants from 14 healthy
donors. B, the allantoin concentration in saliva supernatants was related to
the concentration of LPO. Clear circles are for the individuals with low or no
MPO activity. The association between parameters was determined using
Pearson’s correlation. C, allantoin formation wasmeasured in saliva superna-
tants after incubation for 30 min at 37 °C with no additions (black bars), with
added hydrogen peroxide (50M,white bars), andwith added hydrogen per-
oxide and azide (1 mM, respectively, striped bars). Reactions were stopped by
the addition of catalase (10g/ml). Significant differences (p 0.05) from the
control with no added hydrogen peroxide were determined using repeated
measures ANOVA. Data are means and ranges of at least duplicate experi-
ments.MPO-def, MPO-deficient.D, initial urate concentrations in saliva super-
natants were compared with the increase in allantoin concentration formed
by the addition of hydrogen peroxide (50 M) as in C. The association
between parameters was determined using Pearson’s correlation.
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that of nitrite (E° (NO2 /NO2)  0.99 V), may also assist its
binding in the active site and subsequent oxidation. Indeed, the
rate constant for oxidation of urate by compound I of LPO is
markedly greater than that for compound I of MPO (4.6 105
M1 s1) (23), although the redox potential of the compound
I/compound II couple is higher forMPO than LPO (1.35 versus
1.14V) (51). The stereochemical characteristics of the substrate
binding site in LPOare responsible for the favorable orientation
of thiocyanate, when compared with MPO, and may therefore
also favor binding and subsequent oxidation of urate (64).
The rate constant for reduction of compound II by urate
(8.5 103 M1 s1) was derived by fitting the linear portion of
the plot of the observed rate constants versus urate concentra-
tion. Its magnitude is comparable with that for other organic
substrates of LPO but substantially less than that for serotonin
(3.0  105 M1 s1) (29), suggesting that negative charge and
reduction potential have less influence on oxidation of sub-
strates by this redox intermediate. Rather binding to the active
site may be the crucial factor in substrate oxidation, which is
supported by fact that the plot of the observed rate constants
versus urate concentration plateaus for this reaction at high
urate concentrations. The rate constant for oxidation by com-
pound II is also comparable with that for MPO (1.7 104 M1
s1) (23). In this case, the compound II/ferric couples for MPO
and LPO are similar (0.97 versus 1.04 V) (65). The similarity of
the kinetic and thermodynamic parameters suggests that urate
occupies a similar position in the compound II forms of these
peroxidases. The apparent dissociation constant (200 M) for
urate binding to LPO compound II is comparable with the
Michaelis-Menten constant (100 M) we found during steady
state turnover of urate, suggesting that the binding interaction
of urate and compound II represents the rate-determining step
in the reduction of compound II.
LPO has previously been described as capable of producing
two forms of compound I and II (50, 66), where the electron
hole is stored either as a radical cation on the porphyrin ring or
as an amino acid-based radical, depending on the pH.However,
we found that regardless of whether the compound II species
was formed by slow decay of compound I or fast reduction by
urate, it reacted at the same rate with urate to form ferric LPO.
Consequently, we have no evidence for more than one species
of compound II under our experimental conditions.
Steady state kinetic studies of LPO oxidation of thiocyanate
provided constants that are comparable with those that have
been determined previously for thiocyanate turnover by both
myeloperoxidase and eosinophil peroxidase (56, 67). However,
they revealmajor discrepancieswhen comparedwith the values
previously published for thiocyanate oxidation by LPO (68).
These discrepancies aremost likely due to differences in exper-
imental conditions; the previous study was conducted at pH 5.5
and at hydrogen peroxide concentrations ranging from 0.5 to 1
mM. The experiments presented here were carried out at neu-
tral pH and with comparably low hydrogen peroxide concen-
trations (100M).We believe that our experimental conditions
represent more closely the physiological environment, and at
the same timeminimize undesired irreversible inhibition of the
enzyme.
The steady state oxidation of urate by LPOwas characterized
by biphasic kinetics with an initial fast phase followed by a
slower second phase. Activity assays showed that LPO was not
irreversibly inhibited by urate or by its oxidation products.
Spectroscopic studies suggest that the initial fast phase repre-
sents urate turnover during the classical peroxidase cycle,
whereas the subsequent slower phase represents a second turn-
over cycle, where the enzyme rapidly converts to compound III
and subsequently reverts to compound II at a slower rate (Fig.
11). An analogous mechanism has previously been demon-
strated for oxidation of nitrite and 2,2-azino-bis(3-ethylbenzo-
thiazoline-6-sulfonic acid) by LPO (63). Using stopped-flow
spectroscopy, we were able to show that compound III is
formed during the steady state of urate oxidation, and its for-
mation was linearly dependent on hydrogen peroxide concen-
tration. This plot intersected the origin, which excludes the
possibility that compound III is formed either reversibly or via a
second route, e.g. by the addition of superoxide to the native
enzyme or by reduction of the ferric enzyme and subsequent to
the addition of dioxygen. Consequently, urate and hydrogen
peroxide compete for reaction with compound II under multi-
ple turnover conditions with the eventual conversion of the
enzyme to compound III.
The Michaelis-Menten parameters of urate turnover during
the initial steady state phase (Table 1) reflect the capability of
urate to compete effectively with thiocyanate for oxidation.
However, on the longer time scale, it was apparent that inhibi-
tion of hypothiocyanite production cannot be simply explained
by urate and thiocyanate acting as competitive substrates for
compound I. Instead, reaction of hydrogen peroxide with com-
pound II and diversion of the enzyme away from the halogena-
tion cycle must be invoked to clarify the mechanism of inhibi-
tion. Thus, it appears that the slower second cycle is integral in
describing modulation of LPO activity. This reaction has
FIGURE 11. Suggested catalytic mechanism of LPO in an environment
where similar concentrations of thiocyanate and urate are present. At
low concentrations of hydrogen peroxide, urate will compete with thiocya-
nate for reaction with compound I (Cmpd I). Which substrate dominates will
depend on their relative local concentrations. Urate will also ensure that LPO
is not trapped at compound II (Cmpd II), thereby ensuring continual oxidant
production by the enzyme. At high concentrations of hydrogen peroxide,
LPOwill be converted compound III (Cmpd III), whereas its conversion back to
compound II relies on its slow release of oxygen (55). Under these conditions,
the bactericidal activity of LPO will be inhibited.
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important consequences because we found that under physio-
logically plausible conditions, urate inhibited LPO-dependent
killing of P. aeruginosa by preventing the enzyme from produc-
ing hypothiocyanite.
Ourwork on human saliva supports the proposal that urate is
a physiological substrate for LPO. In agreement with previous
studies, we found that LPO was the dominant peroxidase in
saliva supernatants, and therewere also variable concentrations
of MPO present (25, 58). LPO, but not MPO content, was cor-
related with allantoin in saliva. Ex vivo experiments demon-
strated that peroxidase activity was required for oxidation of
urate in saliva supernatants and was dependent on the urate
concentration. Given the fact that urate was oxidized in saliva
with low MPO, including that from an individual with MPO
deficiency, it is apparent that LPO contributes to the produc-
tion of allantoin in saliva. The degree of urate oxidation was
reliant on urate concentration, which is expected because saliva
contains high concentrations of thiocyanate (0.5–2 mM) (25).
Hence, the higher the concentration of urate, the more likely it
would compete with thiocyanate for oxidation by compound I
of LPO. It is conceivable that other proteins in saliva contain
pseudo-peroxidase activity. However, previous work estab-
lished that LPOandMPOwere by far the dominant peroxidases
in saliva supernatants (25, 58). Consequently, any pseudo-per-
oxidase activity would not compete with much higher concen-
trations of LPO, especially because urate is an excellent sub-
strate for this enzyme.
Exactly how urate affects LPO activity in vivowill depend on
the relative concentrations of urate and thiocyanate as well as
the steady state concentration of hydrogen peroxide. From this
work, it is apparent that the major determinant of LPO activity
in vivo will be the local flux of hydrogen peroxide. Under con-
ditions where hydrogen peroxide produced by NADPH oxi-
dases or xanthine oxidoreductase does not accumulate, LPO is
expected to oxidize thiocyanate via the halogenation cycle and
to oxidize urate via the peroxidase cycle. However, under con-
ditions where oxidase activity exceeds peroxidase activity and
hydrogen peroxide accumulates, thenLPOwill be largely inhib-
ited as urate reduces it to compound II and hydrogen peroxide
diverts it to compound III. Consequently, information on the in
vivo steady state concentrations of hydrogen peroxide is
required before we can fully appreciate the biological action of
LPO. However, it is clear from this work that urate and thiocy-
anate should be considered as competing physiological sub-
strates for LPO. They are present in airway lining fluids at
largely varying concentration ranges (urate: 40–370 M, thio-
cyanate: 50–400 M) (19, 69), so they will compete for oxida-
tion by compound I. It is likely that under most circumstances
thiocyanate is the preferred substrate for compound I and urate
will act simply by preventing accumulation of compound II and
maintaining production of hypothiocyanite. Under some situ-
ations, however, it is possible that urate could be the major
substrate for compound I. For example, in hyperuricemic indi-
viduals who have a diet low in thiocyanate, urate may be the
major substrate. This situation is a potential problem in
patients with cystic fibrosis who are prone to hyperuricemia
(70) and also have defective transport of thiocyanate into the
epithelial lining fluid of their lungs (71). Consequently, LPO,
which is present in the airways, would be less effective at pro-
ducing hypothiocyanite and combatting the frequent infections
these patients suffer, but likely to generate potentially harmful
electrophiles.
In conclusion, our work has shown that urate reacts rapidly
with compound I of LPO and is therefore a likely physiological
substrate for LPOunder conditions of relatively high urate con-
centrationwhen comparedwith thiocyanate. This reactionmay
thus affect host defense by influencing the bactericidal activity
of this enzyme. Further research should be focused on how
hydrogen peroxide, thiocyanate, and urate interact in vivo to
modulate the activity of LPO andwhether the electrophilic spe-
cies generated from urate oxidation are toxic to either invading
bacteria or the host cells.
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